iCo Therapeutics Inc. announced that In connection with the completion of the Arrangement Satellos' board of directors has been reconstituted to include one appointee of iCo, being William Jarosz, and 6 appointees of Pre-Arrangement Satellos, being Geoff Mackay, Frank Gleeson, Michael Rudnicki, Brian Bloom, William McVicar and John Holyoake. Satellos' officers have been reconstituted to include Frank Gleeson as President and Chief Executive Officer and Michael Rudnicki as Chief Scientific Officer. William Jarosz has stepped down as Chief Executive Officer but will continue as Executive Director and Michael Liggett will continue in the role of Interim Chief Financial Officer and Corporate Secretary.